Large-scale testing (Phase 3)Looking for participantsNCT06163326
What this trial is testing
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
Who this might be right for
Vitiligo
Pfizer 400